Kiwi startup OpenStar's bold move to use levitating dipole reactor for fusion achieved a key milestone with its first plasma.

The 3,000-metre distillery has been unveils in the same year the New Zealand spirits brand celebrates a decade in business ...

But 15 months on from La Roja lifting the trophy in Australia and New Zealand, how much has really changed for them ...

DelveInsight's Glucose Syrup Market Insights report provides the current and forecast market analysis, individual leading ...

New Zealand’s banking landscape faces significant changes as new players target different segments, potentially disrupting ...

New Zealand food manufacturers are beginning to embrace the circular economy but are up against a lack of government support, ...

Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...

GSK Plc agreed on a partnership deal worth as much as $650 million with US biotech Vesalius Therapeutics to help advance drug ...

GSK is paying $80 million to ink a multi-target neurodegenerative pact with Flagship-founded Vesalius Therapeutics that ...

A biotech company has plans to begin offering a new type of treatment for some blood cancers, in Christchuch.

"I think it's a reasonable explanation. I think what's happened is due to inflation, Kiwis are buying less New Zealand-made products because they're more expensive, and so therefore sales are down.

Pacific Trade Invest NZ invites you to an important webinar on the FMCG industry in New Zealand. This will be of great ...